H4271 is a broad health care privacy, non-cooperation, and anti-retaliation bill focused on reproductive health care services and gender-affirming health care services. It adds new protections for patients, providers, and related entities by limiting disclosure of names, addresses, contact information, and other personal data; restricting state and local agencies from assisting out-of-state or federal investigations into legally protected health care activity; and barring certain data-sharing from state health information systems, the prescription monitoring program, and the health connector when the request relates to lawful care that occurred, or would have been lawful if it occurred, in Massachusetts.
The bill also creates protections in licensing, insurance, legal practice, and family law. It prevents professional discipline or adverse licensing action based solely on lawful reproductive or gender-affirming care, bars insurers from discriminating against certain nonprofit organizations on that basis, and shields attorneys from discipline for advising clients on these matters. In addition, it directs Massachusetts courts not to treat another state’s adverse findings or laws as a basis for custody, visitation, abuse, or neglect determinations when the issue is a parent allowing a child to receive gender-affirming care, unless the conduct would independently qualify as abuse or neglect under Massachusetts law.
Several sections address medical records and pharmacy practices. The bill requires electronic health record and related systems to segregate certain reproductive and gender-affirming health information, limit access to authorized persons, and prevent disclosure outside Massachusetts without express written patient consent. It also changes labeling rules for certain controlled substances prescribed for these services, allows the use of practice names instead of individual prescriber names in some circumstances, and limits prescription monitoring program reporting and disclosure for those medications unless the Department of Public Health determines reporting is needed to protect public health.
The bill further requires acute-care hospitals to provide emergency services and stabilizing treatment, including abortion when medically necessary to resolve an emergency condition, and authorizes the attorney general to enforce these provisions through civil actions and penalties. It also bars the Department of Public Health from collecting or disseminating identifiable abortion or gender-affirming care surveillance data and makes provider contact information nonpublic. Overall, the measure would significantly expand Massachusetts protections for abortion and gender-affirming care by insulating patients and providers from out-of-state enforcement efforts and by tightening privacy rules across state systems and private entities.
H4271 would amend multiple chapters of the Massachusetts General Laws, including chapters 4, 12, 12C, 31, 66, 93, 94C, 111, 112, 119, 147, 175, 176Q, 208, 209A, 209B, 209C, and 221. Its practical effect would be to create new statutory protections for reproductive health care and gender-affirming health care by limiting state cooperation with outside investigations, restricting disclosure of health and surveillance data, modifying pharmacy labeling and prescription monitoring rules, and establishing enforcement authority for the attorney general in several areas.
The bill would also affect hospitals, health information systems, insurers, licensing boards, attorneys, and courts. It would require certain electronic systems to segregate sensitive records, prohibit some professional discipline and insurance discrimination, and direct family courts to disregard certain out-of-state actions involving gender-affirming care unless the underlying conduct would violate Massachusetts law. Several provisions are delayed in effective date, including the controlled-substance labeling change and the consent-form/health information system requirements.
No committee transcript or vote record was provided, so there is no documented floor or committee sentiment to summarize. Based on the text alone, the bill appears strongly protective of reproductive and gender-affirming care and is framed as a privacy and anti-interference measure. Its structure suggests support from advocates of abortion access, transgender health care, and provider/patient confidentiality, while likely drawing opposition from those concerned about state non-cooperation with law enforcement, limits on data sharing, and the family-law provisions involving out-of-state custody actions.
The main points of contention are likely to be the bill’s limits on cooperation with federal, out-of-state, and private investigations; its restrictions on sharing identifiable health and prescription data; and its family-law provisions that prevent Massachusetts courts from relying on another state’s adverse findings related to gender-affirming care. Opponents may argue these provisions interfere with law enforcement, public health oversight, or interstate comity, while supporters are likely to view them as necessary protections against criminalization and retaliation. Additional likely debate areas include the emergency-room abortion requirement, the pharmacy labeling changes that can obscure individual prescriber identity, and the broad privacy rules for electronic health records and surveillance data.